A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.

These medications have soared in popularity since the FDA first approved Wegovy for weight loss back in 2021. As for what ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

For the first time in a decade, U.S. obesity rates have begun to decline, raising hopes that the nation may be turning a ...

Overall, average healthcare costs increased 46% over two years for patients trying GLP-1 drugs for obesity, from $12,695 to $18,507. The Congressional Budget Office states that there does not ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20 percent of their body weight, on average, a result that caused the Danish ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s ...

Across a sample of nearly 17 million adults in a new JAMA ... from 2013 to 2021. However, in 2022 obesity rates plateaued before decreasing slightly in 2023. Of note, weight loss drugs like ...

The drug has garnered widespread attention for its efficacy in addressing both type 2 diabetes and obesity. With marketing authorizations already secured, the company is now working through final ...